Abstract
GAL‐021 is a novel respiratory stimulant that increases minute ventilation in rats, mice, and Cynomolgus monkeys. We hypothesized that GAL‐021 increases minute ventilation via mechanisms at the level of the carotid body. Using in vivo electrophysiological techniques, we examined the dose‐dependence of the effects of GAL‐021 (0.01 – 3 mg/kg, IV) on carotid sinus nerve (CSN) activity and phrenic motoneuron activity in mechanically ventilated, vagotomized, and neuromuscularly paralyzed adult rats, and on tidal volume (VT) in anesthetized spontaneously breathing rats. GAL‐021 dose‐dependently increased CSN (ED50 0.13 mg/kg) and phrenic nerve neurogram amplitude (ED50 0.08 mg/kg), values in reasonable accord with effects on VT (ED50 0.04 mg/kg). Thus, GAL‐021 is virtually equipotent in stimulating the afferent, efferent and effector components of the ventilatory response. When administered to conscious rats 7 days after either bilateral CSN transection or sham operation, the ventilatory effects (VT and frequency) of GAL‐021 (0.2 mg/kg, IV) were markedly diminished in the CSN transected rats compared to sham‐operated controls. Collectively, these data suggest that GAL‐021 stimulates breathing, at least in part, by effects on the carotid body resulting in increased carotid sinus nerve activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.